Absence of the XIST gene from late-replicating isodicentric X chromosomes in leukaemia. 1994

K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
MRC Molecular Haematology Unit, John Radcliffe Hospital, Headington, Oxford, UK.

The mechanism of X-inactivation in man is thought to involve a specific cis-acting locus within the X-inactivation centre at Xq13 (1,2). The XIST gene (X inactive specific transcript) at Xq13 is ubiquitously expressed only from the inactive X and as such may be involved in or influenced by the X-inactivation process (3,4). We have localised the breakpoints on two acquired isodicentric X chromosomes associated with leukaemia to a 450 kilobase region of DNA within Xq13, which result in deletion of the XIST gene. We have demonstrated that these chromosomes remain inactive and that there is no evidence of XIST expression from the remaining intact X chromosomes. The data suggest that XIST is not required for the maintenance of X-inactivation on these somatically rearranged X chromosomes.

UI MeSH Term Description Entries
D007948 Leukemia, Monocytic, Acute An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES. Leukemia, Monoblastic, Acute,Leukemia, Myeloid, Acute, M5,Leukemia, Myeloid, Schilling-Type,Monoblastic Leukemia, Acute,Monocytic Leukemia, Acute,Myeloid Leukemia, Acute, M5,Myeloid Leukemia, Schilling-Type,Leukemia, Acute Monocytic,Leukemia, Myeloid, Schilling Type,Acute Monoblastic Leukemia,Acute Monoblastic Leukemias,Acute Monocytic Leukemia,Acute Monocytic Leukemias,Leukemia, Schilling-Type Myeloid,Leukemias, Acute Monoblastic,Leukemias, Acute Monocytic,Monoblastic Leukemias, Acute,Monocytic Leukemias, Acute,Myeloid Leukemia, Schilling Type,Schilling-Type Myeloid Leukemia
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004303 Dosage Compensation, Genetic Genetic mechanisms that allow GENES to be expressed at a similar level irrespective of their GENE DOSAGE. This term is usually used in discussing genes that lie on the SEX CHROMOSOMES. Because the sex chromosomes are only partially homologous, there is a different copy number, i.e., dosage, of these genes in males vs. females. In DROSOPHILA, dosage compensation is accomplished by hypertranscription of genes located on the X CHROMOSOME. In mammals, dosage compensation of X chromosome genes is accomplished by random X CHROMOSOME INACTIVATION of one of the two X chromosomes in the female. Dosage Compensation (Genetics),Gene Dosage Compensation,Hypertranscription, X-Chromosome,X-Chromosome Hypertranscription,Compensation, Dosage (Genetics),Compensation, Gene Dosage,Compensation, Genetic Dosage,Dosage Compensation, Gene,Gene Dosage Compensations,Genetic Dosage Compensation,Genetic Dosage Compensations,Hypertranscription, X Chromosome,X Chromosome Hypertranscription
D005260 Female Females
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000754 Anemia, Refractory, with Excess of Blasts Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells. Leukemia, Smoldering,RAEB,RAEM,Refractory Anemia with Excess of Blasts,Leukemia, Smouldering,Leukemias, Smoldering,Smoldering Leukemia,Smoldering Leukemias,Smouldering Leukemia

Related Publications

K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
February 1967, Nature,
K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
July 1979, American journal of human genetics,
K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
November 1977, Tsitologiia,
K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
July 1966, Lancet (London, England),
K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
January 1968, Cytogenetics,
K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
January 1984, The Journal of heredity,
K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
January 1987, Cytogenetics and cell genetics,
K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
March 1974, Annales de genetique,
K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
September 1988, Clinical genetics,
K A Rack, and J Chelly, and R J Gibbons, and S Rider, and D Benjamin, and R G Lafreniére, and D Oscier, and R W Hendriks, and I W Craig, and H F Willard
January 1978, American journal of medical genetics,
Copied contents to your clipboard!